Investing

Cathie Wood's ARK Invest Sells Over 690,000 Shares of Takeda Pharma

jetcityimage / iStock Editorial via Getty Images

One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 690,000 shares of Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) on Tuesday, as the share price of this fund traded was up 2% in the day’s session. Its share price has greatly improved over the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 692,660 shares of Takeda. At Tuesday’s closing price, this would have valued this sale at roughly $9.8 million. This is only a small fraction of the total holdings. This fund is flat over the past 52 weeks.

Here is a quick look at all the other sales that took place across all ARK ETFs:

Fund Ticker Name Shares
ARKF OPEN OPENDOOR TECHNOLOGIES 166,353
ARKF Z ZILLOW 123,790
ARKG INCY INCYTE 6,219
ARKG TAK TAKEDA PHARMACEUTICAL 692,660
ARKG VEEV VEEVA SYSTEMS 31,755
ARKQ LMT LOCKHEED MARTIN 4,885
ARKQ U UNITY SOFTWARE 11,000
ARKW U UNITY SOFTWARE 112,381
ARKX HOFP THALES 15,040

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.

The #1 Thing to Do Before You Claim Social Security (Sponsor)

Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.

A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.

 

Have questions about retirement or personal finance? Email us at [email protected]!

By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.

By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.